(NASDAQ:PCRX), — Third quarter revenues up 6% driven by EXPAREL volume growth of 9% — — Several key milestones advance 5×30 path to growth and value creation — — Conference call today at 4:30 p.m. ET — BRISBANE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its […]
(NasdaqGM:TECX), Positive topline data from Part B of the TX45 Phase 1b trial demonstrated improvements in both left heart function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with reduced Ejection Fraction (“PH-HFrEF”) Expect to initiate TX2100 Phase 1 clinical trial in healthy volunteers in Q1'2026 as a potential treatment
(NASDAQ:ASTE), CHATTANOOGA, Tenn., Nov. 06, 2025 (GLOBE NEWSWIRE) — Astec Industries, Inc. (NASDAQ:ASTE) announced today it will participate in the Baird 2025 Global Industrial Conference on Thursday, November 13, 2025, in Chicago, Illinois. Jaco van der Merwe, President and Chief Executive Officer, Brian Harris, Chief Financial Officer, and Stephen C. Anderson, Senior Vice President of
(NASDAQ:DNLI), Tividenofusp alfa BLA review process for accelerated approval for MPS II continues with productive engagement with the FDA; commercial launch preparations on track DNL126 Phase 1/2 study enrollment completed, supporting an accelerated approval path in MPS IIIA Two new regulatory applications submitted to initiate clinical studies with DNL628 (OTV:MAPT) for Alzheimer's disease and DNL952
(NASDAQ:PTON), Net Income was $14 million, an increase of $15 million year-over-year;Adjusted EBITDA* was $118 million, an increase of $2 million year-over-year;Cash Provided by Operating Activities was $72 million; Free Cash Flow* was $67 million, an increase of $57 million year-over-year NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — Peloton Interactive, Inc. today reported financial
(NASDAQ:CARL), Third quarter revenue of $13.1 million, representing 98% growth YoY Raising full year 2025 revenue guidance to $49 million – $50 million CARLSBAD, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the
(NasdaqGM:TKNO), Third quarter 2025 total revenue was $10.5 million, up 9% from prior yearAchieves five consecutive quarters of year-over-year revenue growthCompany reaffirms 2025 revenue guidance of $39-42 million HOLLISTER, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Alpha Teknova, Inc. (“Teknova” or the “Company”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development,
(NASDAQ:RUN), Aggregate Subscriber Value of $1.6 billion in Q3, 10% growth year-over-year Contracted Net Value Creation of $279 million, 35% growth year-over-year Net change in cash and restricted cash of $144 million and Cash Generation1 of $108 million in Q3, the sixth consecutive quarter of positive Cash Generation Cash Generation guidance for 2025 of $250
(NasdaqGM:USAR),(NasdaqGM:USARW), STILLWATER, Okla., Nov. 06, 2025 (GLOBE NEWSWIRE) — USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company) today announced its financial and operational results for the third quarter and nine months ended September 30, 2025. Third Quarter Highlights Business Highlights Identified a flow sheet for the Round Top development project, validated through bench-
(NasdaqGM:TBCH), -Delivered Net Revenue of $80.5 Million–Gross Margin Improved to 37.4%, a Year-Over-Year Increase of Nearly 120 Basis Points-–Quarterly Net Income of $1.7 Million–Reported Adjusted EBITDA of $11.0 Million–Reiterating Full Year Revenue and EBITDA Guidance- SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) — Turtle Beach Corporation (Nasdaq: TBCH, the “Company”), a leading gaming accessories brand,